Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer. The gene discussed is RBM3; the disease is testicular non-seminomatous germ cell cancer.